Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genetic Therapy constructs promising new antiangiogenic gene therapy

Dec. 15, 2000

Carborane-based retinoid receptor antagonists presented at recent scientific meeting

Dec. 15, 2000

Praecis seeks FDA approval of abarelix depot for prostate cancer

Dec. 15, 2000

Roche presents new antitumor agents acting on cyclin-dependent kinases

Dec. 14, 2000

Angstrom receives SBIR grant for development of uPAR antagonist

Dec. 14, 2000

Zycos begins phase II trial for treatment of cervical dysplasia

Dec. 14, 2000

Nonpeptide cathepsin D inhibitors identified at U. of California

Dec. 12, 2000

GSAO, a novel molecule with the potential to take on both cancer and HIV

Dec. 12, 2000

Phase II clinical trial of 2ME2 commences at Mayo Clinic

Dec. 12, 2000

Myriad Genetics obtains license to cancer drug in phase II

Dec. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...